Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection into the external urethral sphincter for chronic urinary retention after spinal cord injury
2007-003138-41Phase 4Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of neuronox in urinary retention, sponsored by Vall d'Hebron University Hospital. Primary endpoint: Treatment-emergent adverse events. Started Mar 2008; status: completed.
02
Drugs
neuronox
03
Conditions
urinary retention
Beyond the preview
Go deeper on 2007-003138-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003138-41.